Kolexia
Ruszniewski Philippe
Gastro-entérologie
Hôpital Beaujon
Clichy, France
372 Activités
0 Followers

Scientifique
Digital
Production scientifique
Activités par an
Expertise
Sujets de recherche
{{person.topmesh1.name}} Tumeurs neuroendocrines Tumeurs du pancréas Pancréatite Tumeurs du foie Métastase tumorale Tumeur carcinoïde Adénocarcinome Carcinomes Tumeurs de l'intestin

Industries

Ipsen
20 collaboration(s)
Dernière en 2022
Advanced Accelerator Applications
17 collaboration(s)
Dernière en 2022
Sociétés étrangères du groupe AAA
13 collaboration(s)
Dernière en 2023
ADVANCED ACCELERATOR APPLICATIONS
4 collaboration(s)
Dernière en 2023

Dernières activités

Outcome and survival were similar with laparoscopic and open pancreatectomy in 102 solid pseudopapillary neoplasms.
Surgical endoscopy   06 mars 2024
Tumeurs neuroendocrines du pancréas
Bulletin de l'Academie nationale de medecine   28 février 2024
CARECOS study: Medical students' empathy as assessed with the CARE measure by examiners versus standardized patients during a formative Objective and Structured Clinical Examination (OSCE) station.
Medical teacher   29 janvier 2024
Appropriate use of morphological imaging for assessing treatment response and disease progression of neuroendocrine tumors.
Best practice & research. Clinical endocrinology & metabolism   13 octobre 2023
1182O Temozolomide treatment induces an MMR-dependent hypermutator phenotype in well differentiated pancreatic neuroendocrine tumors
Abstract Book of the ESMO Congress 2023, 20 - 24 October 2023.   01 octobre 2023
High Tumor Uptake on F-FDOPA PET/CT Indicates Poor Prognosis in Patients with Metastatic Midgut Neuroendocrine Tumors: A Study from the Groupe d'étude des Tumeurs Endocrines and ENDOCAN-RENATEN Network.
Journal of nuclear medicine : official publication, Society of Nuclear Medicine   31 août 2023
European Neuroendocrine Tumor Society 2023 guidance paper for functioning pancreatic neuroendocrine tumour syndromes.
Journal of neuroendocrinology   14 août 2023
A randomized, open-label, phase 2 study of everolimus in combination with pasireotide LAR or everolimus alone in advanced, well-differentiated, progressive pancreatic neuroendocrine tumors: COOPERATE-2 trial.
Annals of oncology : official journal of the European Society for Medical Oncology   07 août 2023
Management and outcomes of carcinoid heart disease with liver metastases of midgut neuroendocrine tumours.
Heart (British Cardiac Society)   18 juillet 2023
Proposal of early CT morphological criteria for response of liver metastases to systemic treatments in gastroenteropancreatic neuroendocrine tumors: Alternatives to RECIST.
Journal of neuroendocrinology   21 juin 2023